BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This study will be a prospective double blind controlled randomized trial of ten patients
diagnosed with Carpal Tunnel Syndrome (CTS). The study will be completed at offices of
medical practices in Arizona. Patients who meet inclusion criteria will be randomly
distributed into two groups: a BOTOX® (onabotulinumtoxin A) injection group and a Normal
Saline Injection (NS) (Placebo group). Each group will consist of five randomly assigned
individuals.
Phase:
Phase 2
Details
Lead Sponsor:
Benjamin Sucher
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA